DEA Targets Tongue-Twisting Chemical in War on Homemade Meth Labs
Published Date: 10/2/2025
Proposed Rule
Summary
The DEA wants to officially list P2P methyl glycidic acid as a tightly controlled chemical because it’s used to make illegal drugs like methamphetamine. This means anyone handling this chemical, no matter how much, will have to follow strict rules starting as soon as the rule is final. Businesses dealing with this chemical should get ready for new paperwork and regulations to keep things legal and safe.
Analyzed Economic Effects
4 provisions identified: 1 benefits, 3 costs, 0 mixed.
All Transactions Regulated — No Threshold
The proposed rule does not set any transaction threshold: all domestic and international transactions of P2P methyl glycidic acid, regardless of size, would be regulated under the CSA. That means even very small shipments or transfers would fall under the new controls if the rule is finalized.
Mixtures Regulated at Any Concentration
Chemical mixtures that contain any amount of P2P methyl glycidic acid are not exempt from regulation; all transactions of mixtures containing any quantity would be regulated under the CSA. This applies regardless of the concentration of the P2P methyl glycidic acid in the mixture.
P2P Methyl Glycidic Acid Listed
The DEA proposes to list 2-methyl-3-phenyloxirane-2-carboxylic acid (P2P methyl glycidic acid) as a List I chemical under the Controlled Substances Act. If finalized, anyone who handles this chemical will be subject to the CSA’s chemical regulatory rules and must follow those regulations when the rule becomes final.
Manufacturers May Seek Exemption
Manufacturers may submit an application for exemption for mixtures that do not qualify for automatic exemption. That means manufacturers can apply to avoid regulation for certain mixtures through an exemption process when the mixture otherwise would be regulated.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-10090 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) reviewed and decided on applications for special chemical mixtures that don’t fall under strict drug rules, covering requests from July 2025 to March 2026. Some mixtures got approved, others denied, and a few listings were fixed from earlier notices. If you’re involved with these chemicals, you’ve got until July 20, 2026, to share your thoughts—no fees or big costs involved, just your voice!
2026-09566 — Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Starting May 13, 2026, the DEA officially puts CUMYL-PEGACLONE—a chemical that can be risky—into Schedule I, the strictest drug category. This means anyone making, selling, or using it now faces tough rules and penalties. This move helps the U.S. follow international drug laws and keeps communities safer without any new fees or costs.
2026-08595 — Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
The DEA is giving hexahydrocannabinol (HHC) its own official spot on the list of Schedule I drugs, making it clear that HHC is controlled separately from other similar substances. This change starts May 4, 2026, and affects anyone making, selling, or using HHC, which stays illegal under federal law. No new fees or costs are introduced, but the update helps law enforcement and businesses know exactly where HHC stands.
2026-08587 — Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
ANI Pharmaceuticals wants to import certain controlled drugs like Levorphanol and Tapentadol. People who make or use these drugs can share their thoughts or ask for a hearing by June 3, 2026. This move could affect drug availability and regulation, so keep an eye on the deadline to have your say!
2026-08588 — Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Patheon API Inc. wants to make large amounts of special research drugs like dimethyltryptamine and psilocybin. This affects researchers and companies involved in clinical trials, with a chance to comment or ask for a hearing by July 6, 2026. No money changes are mentioned, but this move could speed up important medical studies.
Previous / Next Documents
Previous: 2025-19363 — Fishery Management Plans of St. Croix and St. Thomas and St. John; Queen Triggerfish Management Measures
Fishermen and seafood lovers around St. Croix, St. Thomas, and St. John, listen up! New rules are coming to adjust how many queen triggerfish can be caught each year to keep the fish population healthy and strong. These changes, based on fresh science, aim to stop overfishing and make sure there’s plenty of fish for the future—starting as soon as the rule is official.
Next: 2025-19385 — Fisheries of the Exclusive Economic Zone Off Alaska; Modify the Timing of Haul Designation for Trawl Catcher Processors in the Gulf of Alaska and Bering Sea and Aleutian Islands Groundfish Fisheries
This rule change helps fishing boats in Alaska’s Gulf and Bering Sea take a bit more time to decide how to label their fish hauls. It mainly affects trawl catcher/processors, making their work smoother and fairer, especially for those juggling different fishing programs on one trip. The update aims to keep fishing fair and organized without messing with money or deadlines.